InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Explore the full record of transactions filed by Salzmann Peter, Chief Executive Officer. Insider active across 1 companies, notably Immunovant, Inc.. Aggregated, 8 filings have been recorded. Total volume traded: €1.7m. The latest transaction was filed on 29 June 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations8 total
€5,2951,376 shares@ €3.84810.0001% mcap0.3% of flow
Common Stock
SEC:0001764013-22-000072:0·
€5,1931,471 shares@ €3.530.0001% mcap0.3% of flow
Common Stock
SEC:0001764013-22-000045:0·
€7,2531,622 shares@ €4.47180.0001% mcap0.4% of flow
Common Stock
SEC:0001764013-22-000041:0·
€103,06819,227 shares@ €5.36060.0018% mcap6.0% of flow
Common Stock
SEC:0001764013-22-000035:0·
€803,227125,158 shares@ €6.41770.014% mcap100.0% of flow
Common Stock
SEC:0001764013-22-000009·
€803,227125,158 shares@ €6.41770.014% mcap46.5% of flow
Common Stock
SEC:0001764013-22-000009:0·
0570,613 shares0
Common Stock
SEC:0001764013-21-000068·
0570,613 shares0
Common Stock
SEC:0001764013-21-000068:0·
8 of 8 declarations
About Salzmann Peter
Peter Salzmann is the Chief Executive Officer of Immunovant, Inc. He leads the company with a focus on innovation and the development of new treatments. With significant experience in the biopharmaceutical sector, Peter Salzmann contributes to operational optimization and company growth. His leadership is essential for achieving strategic objectives at Immunovant.
